Total Payments
$2,328
2024 Payments
$205.13
Companies
34
Transactions
156
Medicare Patients
2,827
Medicare Billing
$822,561
Payment Breakdown by Category
Food & Beverage$2,267 (97.4%)
Education$61.20 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,267 | 155 | 97.4% |
| Education | $61.20 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $299.40 | 21 | $0 (2024) |
| PFIZER INC. | $262.37 | 20 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $200.96 | 7 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $190.98 | 13 | $0 (2024) |
| Lilly USA, LLC | $179.42 | 13 | $0 (2024) |
| Amgen Inc. | $116.84 | 8 | $0 (2022) |
| Novo Nordisk Inc | $89.08 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $88.47 | 3 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $85.59 | 9 | $0 (2020) |
| AKEBIA THERAPEUTICS INC | $76.72 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $205.13 | 13 | Almatica Pharma LLC ($44.66) |
| 2023 | $249.14 | 17 | PFIZER INC. ($57.54) |
| 2022 | $151.74 | 11 | Amgen Inc. ($30.00) |
| 2021 | $357.78 | 26 | Fresenius USA Marketing, Inc. ($102.17) |
| 2020 | $284.10 | 21 | Lilly USA, LLC ($54.56) |
| 2019 | $530.81 | 28 | Novartis Pharmaceuticals Corporation ($159.93) |
| 2018 | $278.28 | 23 | PFIZER INC. ($73.78) |
| 2017 | $271.10 | 17 | PFIZER INC. ($41.32) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/11/2024 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), LAGEVRIO | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Nephrology | ||||||
| 09/03/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: ANTI-ANXIETY | ||||||
| 08/28/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/24/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: ANTI-ANXIETY | ||||||
| 07/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Nephrology | ||||||
| 04/01/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/21/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Diabetes Care | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.54 | General |
| 11/13/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Nephrology | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: VACCINES | ||||||
| 07/26/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/24/2023 | Almatica Pharma LLC | LOREEV XR (Drug), GRALISE | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ANTI-ANXIETY | ||||||
| 07/18/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: VACCINES | ||||||
| 07/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 07/14/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Nephrology | ||||||
| 06/15/2023 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 523 | 1,275 | $468,066 | $155,516 |
| 2022 | 16 | 658 | 1,617 | $588,046 | $196,652 |
| 2021 | 18 | 784 | 1,866 | $651,064 | $231,245 |
| 2020 | 20 | 862 | 2,032 | $445,952 | $239,149 |
Total Patients
2,827
Total Services
6,790
Medicare Billing
$822,561
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 38 | 219 | $198,491 | $64,444 | 32.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 41 | 129 | $96,776 | $31,988 | 33.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 74 | 311 | $29,844 | $13,005 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 167 | $38,605 | $11,458 | 29.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 18 | 52 | $26,718 | $8,824 | 33.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 119 | $21,384 | $8,049 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 48 | $15,744 | $4,659 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 39 | $13,268 | $4,338 | 32.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 34 | 45 | $11,384 | $3,194 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $5,523 | $1,892 | 34.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 14 | 19 | $3,481 | $1,157 | 33.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,550 | $1,051 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 48 | 70 | $525.00 | $514.50 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $1,125 | $509.55 | 45.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 13 | 13 | $650.00 | $435.37 | 67.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 48 | 303 | $274,624 | $91,526 | 33.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 46 | 126 | $94,525 | $32,013 | 33.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 77 | 234 | $42,050 | $14,320 | 34.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 97 | 379 | $36,369 | $12,530 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 139 | $32,133 | $9,688 | 30.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 18 | 44 | $22,607 | $7,661 | 33.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 59 | $20,072 | $6,760 | 33.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 74 | $19,108 | $6,506 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 34 | $11,152 | $3,401 | 30.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 35 | 39 | $9,866 | $3,355 | 34.0% |
About Dr. James Agresti, D.O
Dr. James Agresti, D.O is a Nephrology healthcare provider based in Kenilworth, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306931837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Agresti, D.O has received a total of $2,328 in payments from pharmaceutical and medical device companies, with $205.13 received in 2024. These payments were reported across 156 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,267).
As a Medicare-enrolled provider, Agresti has provided services to 2,827 Medicare beneficiaries, totaling 6,790 services with total Medicare billing of $822,561. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Kenilworth, NJ
- Active Since 10/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306931837
Products in Payments
- LOKELMA (Drug) $227.97
- Velphoro (Drug) $190.98
- ENTRESTO (Drug) $186.42
- CHANTIX (Drug) $86.90
- TRULICITY (Drug) $78.58
- JARDIANCE (Drug) $73.97
- FARXIGA (Drug) $71.43
- Ozempic (Drug) $63.43
- SAMSCA (Drug) $61.20
- LONHALA MAGNAIR (Drug) $60.86
- LOREEV XR (Drug) $59.42
- Parsabiv (Drug) $57.87
- PREVNAR 20 (Biological) $54.50
- Natesto (Drug) $53.47
- Veltassa (Drug) $51.20
- LYRICA (Drug) $49.73
- Dymista (Drug) $46.31
- Auryxia (Drug) $45.49
- AFREZZA (Drug) $43.89
- AURYXIA (Drug) $43.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.